MRSO (TSE:5619) Research & Development: 円0.0 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:5619 MRSO Inc TSE:5619
20 GF Score
Price 円834.00
! 2 Warning Signs
View Full Analysis

What is MRSO Research & Development?

MRSO TSE:5619 20 Research & Development is 円0.0 Mil as of Dec. 2025. GuruFocus rates TSE:5619 with a GF Score™ of 20/100. The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. MRSO's Research & Development for the three months ended in Dec. 2025 was 円0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was 円0.0 Mil.

MRSO  (TSE:5619) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

MRSO Research & Development Related Terms

MRSO Research & Development Historical Data

* Premium members only.

The historical data trend for MRSO's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MRSO Research & Development Chart

MRSO Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
0.00 0.00 0.00 0.00 0.00

MRSO Quarterly Data
Dec21 Dec22 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:5619
20GF Score
MRSO Inc TSE:5619
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MRSO Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of 円0.0 Mil mean?
MRSO (TSE:5619) has a Research & Development of 円0.0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on MRSO and its competitors.
Is MRSO's Research & Development too high?
MRSO's current Research & Development is 円0.0 Mil. Overall, MRSO has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does MRSO's Research & Development compare to VEEV and BTSG?
MRSO's Research & Development of 円0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on MRSO and its competitors. MRSO's current Research & Development is 円0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MRSO stock overvalued right now?
MRSO (TSE:5619) has a current Research & Development of 円0.0 Mil. The current Research & Development is 円0.0 Mil. MRSO's overall GF Score™ is 20/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For MRSO (TSE:5619), the current Research & Development is 円0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MRSO Business Description

Address Shiroyama Trust Tower 17th floor, 4-3-1 Toranomon, Minato-ku, Tokyo, JPN, 105-6017
MRSO Inc operates a healthcare platform and provides vertical SaaS solutions for medical institutions, government entities, and corporations. The company offers a preventive medical platform that enables reservations for medical checkups and various cancer screenings. It also provides administrative DX services that support tasks carried out by local governments, including the acceptance of reservations for resident health checkups and vaccinations. These administrative DX services are used by local governments across regions with varying population sizes.
20GF Score

Get the complete analysis for TSE:5619

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円834.00
Price